Pages that link to "Q38854987"
Jump to navigation
Jump to search
The following pages link to Physiological and pathological cardiac hypertrophy. (Q38854987):
Displaying 50 items.
- Neuronal nitric oxide synthase in hypertension - an update (Q28077204) (← links)
- New Treatment Strategies for Alcohol-Induced Heart Damage (Q28078093) (← links)
- Effects of Active Components of Fuzi and Gancao Compatibility on Bax, Bcl-2, and Caspase-3 in Chronic Heart Failure Rats (Q28354136) (← links)
- Novel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease (Q30235583) (← links)
- Protective effect of hydrogen sulphide against myocardial hypertrophy in mice (Q33618317) (← links)
- Protective Role for LPA3 in Cardiac Hypertrophy Induced by Myocardial Infarction but Not by Isoproterenol (Q33736651) (← links)
- Non-coding RNAs in cardiac hypertrophy. (Q33800147) (← links)
- Etanercept protects rat cardiomyocytes against hypertrophy by regulating inflammatory cytokines secretion and cell apoptosis (Q33821362) (← links)
- MicroRNA-497 Inhibits Cardiac Hypertrophy by Targeting Sirt4 (Q36228490) (← links)
- Role of Jagged1-Hey1 Signal in Angiotensin II-induced Impairment of Myocardial Angiogenesis (Q37640961) (← links)
- Bioinformatics Analysis Reveals MicroRNAs Regulating Biological Pathways in Exercise-Induced Cardiac Physiological Hypertrophy (Q37670773) (← links)
- PKD knockdown inhibits pressure overload-induced cardiac hypertrophy by promoting autophagy via AKT/mTOR pathway (Q37726215) (← links)
- Akt2 ablation prolongs life span and improves myocardial contractile function with adaptive cardiac remodeling: role of Sirt1-mediated autophagy regulation (Q38691645) (← links)
- Sarcoplasmic reticulum-mitochondria communication in cardiovascular pathophysiology. (Q39169425) (← links)
- Epigenetics, inflammation and metabolism in right heart failure associated with pulmonary hypertension (Q39382663) (← links)
- Corticotropin releasing hormone receptor 2 exacerbates chronic cardiac dysfunction. (Q40183419) (← links)
- Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload (Q40508366) (← links)
- PEG-coated gold nanoparticles attenuate β-adrenergic receptor-mediated cardiac hypertrophy (Q40970624) (← links)
- Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload (Q41660276) (← links)
- Sanggenon C protects against pressure overload‑induced cardiac hypertrophy via the calcineurin/NFAT2 pathway (Q42679042) (← links)
- Zinc-finger protein 418 overexpression protects against cardiac hypertrophy and fibrosis (Q45747384) (← links)
- Phenotype and Clinical Outcomes of Titin Cardiomyopathy. (Q46159261) (← links)
- Apocynin prevents isoproterenol-induced cardiac hypertrophy in rat. (Q46236892) (← links)
- Treatment of the cardiac hypertrophic response and heart failure with ginseng, ginsenosides, and ginseng-related products (Q46365654) (← links)
- Andrographolide Protects against Aortic Banding-Induced Experimental Cardiac Hypertrophy by Inhibiting MAPKs Signaling (Q47098056) (← links)
- Respecting boundaries: CTCF, chromatin structural organization, and heart failure (Q47170640) (← links)
- Quantitative trait mapping in Diversity Outbred mice identifies two genomic regions associated with heart size (Q47172951) (← links)
- Mammalian target of rapamycin inhibition attenuates myocardial ischaemia-reperfusion injury in hypertrophic heart. (Q47218873) (← links)
- Palmatine attenuates isoproterenol-induced pathological hypertrophy via selectively inhibiting HDAC2 in rats (Q47374623) (← links)
- Genistein attenuates pathological cardiac hypertrophy in vivo and in vitro (Q47442545) (← links)
- A20 prevents obesity-induced development of cardiac dysfunction. (Q47578354) (← links)
- ER Protein Quality Control and the Unfolded Protein Response in the Heart. (Q47659541) (← links)
- A microfluidic platform for the high-throughput study of pathological cardiac hypertrophy (Q47765828) (← links)
- Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner. (Q48146412) (← links)
- The TRPM4 channel is functionally important for the beneficial cardiac remodeling induced by endurance training (Q48209998) (← links)
- Cucurbitacin B Protects Against Pressure Overload Induced Cardiac Hypertrophy. (Q48301430) (← links)
- Polymorphisms/Mutations in A-Kinase Anchoring Proteins (AKAPs): Role in the Cardiovascular System (Q49693707) (← links)
- A Disintegrin and Metalloprotease-22 Attenuates Hypertrophic Remodeling in Mice Through Inhibition of the Protein Kinase B Signaling Pathway (Q49875840) (← links)
- Aucubin protects against pressure overload-induced cardiac remodelling via β3-AR-nNOS cascades. (Q49977036) (← links)
- Caspase-1 regulate AngII-induced cardiomyocyte hypertrophy via upregulation of IL-1β. (Q50026322) (← links)
- Cardiac specific expression of ∆H2-R15 mini-dystrophin normalized all ECG abnormalities and the end-diastolic volume in a 23-m-old mouse model of Duchenne dilated cardiomyopathy. (Q50058440) (← links)
- Differential microRNA expression profiles and bioinformatics analysis between young and aging spontaneously hypertensive rats (Q50068185) (← links)
- Physiological and pathological gestational cardiac hypertrophy: what can we learn from rodents? (Q50074783) (← links)
- Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy (Q50089772) (← links)
- SOX2-mediated inhibition of miR-223 contributes to STIM1 activation in phenylephrine-induced hypertrophic cardiomyocytes (Q50129421) (← links)
- The Histone Demethylase JMJD2A Modulates the Induction of Hypertrophy Markers in iPSC-Derived Cardiomyocytes (Q50238711) (← links)
- The role of heat shock proteins and co-chaperones in heart failure. (Q51424623) (← links)
- FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca2+ /calmodulin-mediated signalling pathways in vivo and in vitro. (Q52691676) (← links)
- Exercise Training and Epigenetic Regulation: Multilevel Modification and Regulation of Gene Expression. (Q52746297) (← links)
- FGF23 Actions on Target Tissues-With and Without Klotho. (Q54960612) (← links)